~~<i id='B3363D9C5E'><strike id='B3363D9C5E'><tt id='B3363D9C5E'><pre id='B3363D9C5E'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

author：knowledge 2025-08-07 23:38:57 Page View：97372

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma
Next article： In Memoriam: Notable people who died in 2023

comprehensive

State Dept. review finds Biden bears some blame for Afghanistan failures

3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

Surprise medical billing ban raises prices elsewhere

ANGELAWEISS/AFPviaGettyImagesWithoutquestion,thenewfederallawbanningsurprisebillingisachievingitsgoa

Sports medicine is finally prioritizing gender equality

MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

Study: Adult vaccinations pay for themselves in societal benefits

FREDERICJ.BROWN/AFPviaGettyImagesThenumberofchildrenwhoreceivedtheirroutinevaccinationsdeclineddurin